These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial. Hasegawa T, Ako J, Koo BK, Miyazawa A, Sakurai R, Chang H, Dens J, Verheye S, Grube E, Honda Y, Fitzgerald PJ. Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):34-41. PubMed ID: 19089934 [Abstract] [Full Text] [Related]
7. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W. JACC Cardiovasc Interv; 2013 Oct 01; 6(10):1026-34. PubMed ID: 24055443 [Abstract] [Full Text] [Related]
8. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial. Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T. EuroIntervention; 2016 Apr 20; 11(13):1457-67. PubMed ID: 25947278 [Abstract] [Full Text] [Related]
9. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial. Grundeken MJ, Garcia-Garcia HM, Kumsars I, Lesiak M, Kayaert P, Dens J, Stella PR, de Winter RJ, Laak LL, Généreux P, Kaplan AV, Leon MB, Wykrzykowska JJ, Onuma Y, Serruys PW. Catheter Cardiovasc Interv; 2017 Feb 01; 89(2):E53-E63. PubMed ID: 27083384 [Abstract] [Full Text] [Related]
10. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system. Triantafyllis AS, Bennett J, Pagourelias E, McCutcheon K, Adriaenssens T, Sinnaeve PR, Desmet W, Dubois C. Cardiol J; 2018 Feb 01; 25(4):470-478. PubMed ID: 29240962 [Abstract] [Full Text] [Related]
11. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study. Bartorelli AL, Trabattoni D, Almonacid A, Fabbiocchi F, Montorsi P, Galli S, Grancini L, Ravagnani P, Mintz GS, Kaplan AV, Popma JJ, Maehara A. Catheter Cardiovasc Interv; 2015 Mar 01; 85(4):544-53. PubMed ID: 25115944 [Abstract] [Full Text] [Related]
13. Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study. Buysschaert I, Dubois CL, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger JP, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky AJ, Bichalska M, Meis S, Verheye S. EuroIntervention; 2013 Sep 01; 9(5):573-81. PubMed ID: 24058075 [Abstract] [Full Text] [Related]
14. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial. Bennett J, Adriaenssens T, Desmet W, Dubois C. Catheter Cardiovasc Interv; 2016 Nov 15; 88(6):843-853. PubMed ID: 27184586 [Abstract] [Full Text] [Related]
16. Impact of kissing balloon inflation on the main vessel stent volume, area, and symmetry after side-branch dilation in patients with coronary bifurcation lesions: a serial volumetric intravascular ultrasound study. Rahman S, Leesar T, Cilingiroglu M, Effat M, Arif I, Helmy T, Leesar MA. JACC Cardiovasc Interv; 2013 Sep 15; 6(9):923-31. PubMed ID: 23954062 [Abstract] [Full Text] [Related]
18. Efficacy of biolimus A9-eluting stent for treatment of right coronary ostial lesion with intravascular ultrasound guidance: a multi-center registry. Nasu K, Oikawa Y, Habara M, Shirai S, Abe H, Kadotani M, Gotoh R, Hozawa H, Ota H, Suzuki T, Shibata Y, Tanabe M, Nakagawa Y, Serikawa T, Nagasaka S, Takeuchi Y, Fujimoto Y, Tamura H, Kobori Y, Yajima J, Aizawa T, Suzuki T, NO-RECOIL Registries Investigators. Cardiovasc Interv Ther; 2018 Oct 15; 33(4):321-327. PubMed ID: 28929334 [Abstract] [Full Text] [Related]
19. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial. Antonsen L, Maeng M, Thayssen P, Christiansen EH, Hansen KN, Kaltoft A, Hansen HS, Thuesen L, Lassen JF, Jensen LO. Catheter Cardiovasc Interv; 2014 May 01; 83(6):864-72. PubMed ID: 23996918 [Abstract] [Full Text] [Related]
20. Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial. Yamasaki M, Tsujino I, Lima-Filho MO, Ako J, Shimohama T, Hasegawa T, Sakurai R, Sudhir K, Stone GW, Waseda K, Honda Y, Fitzgerald PJ. EuroIntervention; 2012 Oct 01; 8(6):724-31. PubMed ID: 23086791 [Abstract] [Full Text] [Related] Page: [Next] [New Search]